Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID-OUT: Early Outpatient Treatment for COVID-19
NCT04510194Phase 3Completed
- Sponsor
- University of Minnesota
- Start
- Jan 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metformin, fluvoxamine, ivermectin in coronavirus disease 2019 (COVID-19), sponsored by University of Minnesota. Started Jan 2021; status: completed.
02
Drugs
metforminfluvoxamineivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04510194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04510194.